The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Dashboard: Filter Bricks
Main page content
Displaying results 1 - 4 of 4
Publication ID: PEP21-02-01-003
Published:
Publication ID: PEP21-02-01-002
Published:
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.
Publication ID: SMA19-5094-PO
Published:
This poster is for clients and their family members in OUD treatment who are pregnant or who are currently not pregnant but of childbearing age.
Publication ID: SMA19-5094-FS
Published:
This fact sheet is for women who are pregnant or of childbearing age with an opioid use disorder